Global Cancer Monoclonal Antibodies Market 2017-2021

Price :
Published : Dec-2016
No. of Pages : 115

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.

The analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, This report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • F. Hoffmann-La Roche
  • Amgen
  • Bristol-Myers Squibb
  • Takeda Pharmaceuticals

Other prominent vendors

  • AbbVie
  • ADC Therapeutics
  • Agensys
  • Argos Therapeutics
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Biotech Pharmaceutical
  • BioGenomics
  • Boehringer Ingelheim
  • Celldex Therapeutics
  • Chugai Pharmaceutical
  • CTI BioPharma
  • Daiichi Sankyo
  • Eli Lilly
  • Fortress Biotech
  • Genmab
  • Immunomedics
  • Intas Pharmaceuticals
  • Janssen Biotech
  • Kyowa Hakko Kirin
  • Merck
  • MedImmune
  • Morphotek
  • Neovii Biotech
  • Novartis
  • OncoMed Pharmaceuticals
  • Pfizer
  • Sanofi
  • Seattle Genetics
  • TG Therapeutics
  • Xbiotech

Market driver

  • Increase in demand for ADCs
  • For a full, detailed list, view our report

Market challenge

  • Complicated regulatory framework
  • For a full, detailed list, view our report

Market trend

  • Emergence of targeted and combination therapies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Medpace Inc (MEDP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization's services comprise medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial management, biostatistics and data sciences, drug safety and pharmacovigilance, quality assurance, core labs and technology services. It offers research in the therapeutic areas of metabolism, cardiology, oncology, infectious disease, nephrology, regenerative medicine, and gastrointestinal disorders. The organization operates in Australia, the US and other European, Asian, the Middle East, African, and the American countries. Medpace is headquartered in Cincinnati, Ohio, the US. Medpace Inc (MEDP) - P......

Megapharm Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Megapharm Ltd (Megapharm) is a biotechnology company which offers marketing services. It is engaged in marketing of pharmaceutical products for international companies. Megapharm markets a wide range of products in various therapeutic areas such as dermatology, gastroenterology, central nervous system, oncology, rheumatology, urology, respiratory and allergy, and gynaecology, among others. The company also provides clinical research services such as regulatory guidance, safety reporting, clinical monitoring, drug import and storage. It also provides consultation and supervision services to its partners associated with the clinical studies in Israel. The company has partners in Germany, Switzerland, Ireland, Cyprus, Austria and the UK, among others. Megapharm is headquartered in ......

Cold Spring Harbor Laboratory – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution's research services include graduate research, research training, clinical research, quantitative biology research, postdoctoral research, disease research, and scientific research services. Its educational services comprise undergraduate research programs, postgraduate programs, Ph.D. programs, education resources programs, DNA learning centres services, and primary and secondary educational services. CSHL conducts research in the fields of cancer, plant biology, neuroscience, bioinformatics, quantitative biology, genomics, and biological sciences. The institution provides diagnosis and treatment of cancer, neurological disorders and ......

Miltenyi Biotec GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company's services include sample preparation, cell separation, flow cytometry, cell culture and stimulation, molecular, clinical applications and viscover imaging. It also offers cytometers, analyzers, reagents, buffers, imaging instruments, and software solutions. Miltenyi conducts research in the areas of oncology, cardiovascular disease, metabolic disorders, immunology, neurology and infection. The company has presence in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea, and others. Miltenyi is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Ger......

ATI Physical Therapy – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening services. Its workers' comp rehab services comprise treatment for increase strength, endurance and cardio function; earned international recognition for our outcomes and results and conduct functional capacity evaluations. The center offers development of women healths which include reduce pelvic floor pain, weakness and dysfunction; address incontinence issues, manage prenatal and postpartum pain; and surgery recovery services. ATI is headquartered in Bolingbrook, Illinois, the US. ATI Physical......

Pfenex Inc (PFNX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company's lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple sclerosis; PF708, a peptide product candidate to treat high-risk fracture patients; and others. Pfenex's preclinical products under development include PF529, a biosimilar candidate to neulasta; PF688, a biosimilar candidate to cimzia, PF444, PF690; and others. The company produces biosimilar product with protein production platform and bioanalytic approach. It partners with the US government for developing vaccines for anthrax and malaria. Pfenex is headquartered in San Diego, California, the U......

Crohn’s & Colitis Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization which focuses on providing treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. CCF's partners include European Federation of Crohn's and Ulcerative Colitis Associations, International Organization of Inflammatory Bowel Disease (IOIBD) and International Ostomy Association. It supports ongoing research initiatives and clinical studies to encourage cooperation among investigators, research centers, and other resources.The organization works in collaboration with healthcare providers and caregivers to deliver education, awareness and support services through patient-centric education and ad......

Monopar Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company's pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. Its huATN-658 targets the urokinase plasminogen activator receptor. Monopar builds development pipeline through the licensing or acquisition of orphan oncology therapeutics at the preclinical through advanced clinical development stage. The company's lead drug product candidate is entering into clinical development through collaboration with research center in the UK. It operates in San Francisco, California, Chicago, and Illinois. Monopar is headquartered in Lake Forest, Illinois, the US. ......

Centre for Drug Design and Discovery – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution provides services such as silico molecule design, modelling and screening, medicinal chemistry, intellectual property rights support, business development, and others. It partners with various research institutions and companies to offer drugs for various disorders such as epilepsy, cancer, acquired immunodeficiency syndrome (AIDS), hepatitis C virus infections, arthritis, asthma, dengue virus infections, and Alzheimer's disease. CD3 concentrates on various types of projects such as screening projects, rational design projects, and hit-to-lead projects. It also offers drug discovery and development services for the treatment of all kinds of dis......

LSK BioPartners Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary LSK BioPartners Inc (LSK BioPartners) dba LSK BioPharma is a biopharmaceutical company which develops therapies for unmet medical needs in cancer. The company is developing proprietary drug candidate apatinib, a selective VEGFR-2 inhibitor for the treatment of solid tumor cancers such as metastatic gastric carcinoma, colorectal cancer, hepatocellular carcinoma, metastatic breast cancer and non-small cell lung cancer. LSK BioPartners has also acquired license for the manufacturing and commercialization of HCI-1401, a selective bruton's tyrosine kinase (BTK/JAK3) inhibitor for the treatment of hematologic malignancies and rheumatoid arthritis. The company has collaborations with University of Utah's Huntsman Cancer Institute, Bukwang Pharma Co. Ltd., HLB Co. Ltd. and Asan Medical ......